Skip to main content

Table 2 Association between LYRM4 protein expression and various clinicopathological factors in LIHC patients

From: Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma

Variables

LYRM4 protein expression

p value

Low (n = 43)

High (n = 49)

Gender

 Male

36

41

0.9951

 Female

7

8

 

History of drinking

 Yes

12

20

0.2226

 No

30

29

 

Hepatitis B

 Yes

30

41

0.7605

 No

2

2

 

History of smoking

 Yes

17

20

0.8363

 No

26

28

 

Liver cirrhosis

 Yes

33

31

0.1610

 No

10

18

 

History of Hepatitis

 Yes

28

34

0.6628

 No

15

15

 

Grade (G)

 G1–G2

37

41

0.8785

 G3

5

5

 

TNM stage

 I–II

31

33

0.6216

 III–IV

12

16

 

Tumor thrombus

 Yes

11

15

0.5973

 No

31

33

 

Tumor encapsulation

 Yes

6

4

0.2790

 No

31

43

 

Tumor size

3.65 (2.2, 6.13)

3 (2.0, 5)

0.1850

Age

59 ± 10.9

55 ± 8.4

0.0410

ALB (g/L)

35.9 ± 5.1

37.1 ± 4.8

0.2240

LDL (mmol/L)

2.0 ± 0.7

2.3 ± 0.8

0.0340

AFP (ng/mL)

16.7 (3.9, 291.7)

32.2 (4.7, 388.3)

0.5340

TBIL (mmol/L)

13 (11, 21.5)

12 (10, 17)

0.4100

DBIL (mmol/L)

7 (5, 10.3)

6 (4.5, 9)

0.3030

IBIL (mmol/L)

6 (5, 10)

6 (5, 9)

0.6600

ALT (U/L)

53.5 (30.8, 116)

52 (36, 86.5)

0.8750

AST (U/L)

37.5 (27, 53.5)

34 (23.5, 57.5)

0.5650

ALP (U/L)

89.5 (73.8, 122.3)

94 (75.5, 118)

0.8600

TG (mmol/L)

0.9 (0.7, 1.1)

1.1 (0.9, 1.5)

0.0130

  1. The bold values indicate the significant difference between the two groups of data, and the statistical significance was set at p < 0.05